Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,163
Recruiting: 2,261
Ph III recruiting: 270
Growth YoY: +12.5%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 2,151–2,200 of 2,282 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01417442	BRAF V600E Mutations In Papillary Thyroid Carcinoma	unknown	Early Phase 1	150	Bezmialem Vakif UniversityOTHER	1	Aug 16, 2011	clinicaltrials
NCT01417806	Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer	unknown	Phase 2	28	South Florida Veterans Affairs Foundation for Research and EducationFED	1	Aug 16, 2011	clinicaltrials